Chemical Sunscreen Filters: What the FDA Absorption Trials Showed, and What They Did Not

Chemical sunscreens are popular for one visible reason: they rub in clear. They are also the subject of a persistent question, because FDA researchers showed that several of their filters reach the bloodstream. This guide separates what those trials measured from what they did not, and explains how to choose a lightweight formula without overreading the headlines.

What counts as a chemical filter

Sunscreen filters fall into two broad groups. Mineral filters, zinc oxide and titanium dioxide, sit on the surface and leave the pale cast many people dislike. Chemical filters, also called organic filters, are dissolved in the formula and absorb UV. The common US names are avobenzone, octocrylene, homosalate, octisalate, octinoxate and oxybenzone, plus ecamsule in a few products. These six or seven names are the ones studied in the trials below, which is why the trials matter for anyone reading a label.

What the 2019 FDA trial measured

In 2019, FDA researchers published a randomized trial in JAMA with 24 healthy volunteers, 23 of whom completed it. Participants applied sunscreen at 2 mg/cm2 to 75% of the body surface four times a day for four days, and blood was drawn 30 times over seven days. The products were two sprays, a lotion and a cream containing avobenzone, oxybenzone, octocrylene and ecamsule.

Every product produced blood levels above 0.5 ng/mL, the FDA threshold used to decide whether some additional safety studies may be waived. The reported peak averages were about 4.0, 3.4 and 4.3 ng/mL for avobenzone across the sprays and lotion, and 169.3 to 209.6 ng/mL for oxybenzone. The authors called the study preliminary and wrote that the results do not indicate people should refrain from using sunscreen.

What the 2020 follow-up added

A 2020 JAMA trial enrolled 48 healthy adults, of whom 44 completed it, split across four formulations: a lotion, an aerosol spray, a non-aerosol spray and a pump spray. It tested six filters: avobenzone, oxybenzone, octocrylene, homosalate, octisalate and octinoxate. The first-day dose was one application, followed by four applications a day on days two through four.

All six exceeded the 0.5 ng/mL threshold, including after a single application on day one. Peak averages varied widely by ingredient and product: avobenzone was around 3.3 to 7.1 ng/mL, octocrylene about 6.6 to 7.8 ng/mL, and oxybenzone as high as 258.1 ng/mL in the lotion. The most common adverse event was a rash, reported by 14 participants. The authors repeated that the findings do not indicate people should avoid sunscreen. JAMA also issued a March 2020 erratum correcting some table and figure values, so check the corrected version before quoting exact numbers.

What these trials do not show

It matters what a threshold means. Crossing 0.5 ng/mL does not mean an ingredient is harmful. It means the ingredient is absorbed enough that standard additional testing is no longer automatically waived. Both papers say the clinical significance is unknown and call for more work.

The conditions were also extreme by design. Maximal-use testing means a heavy 2 mg/cm2 layer over three quarters of the body, repeated several times a day. Applying a face-sized amount once in the morning is a very different exposure. The trials were short, used healthy adults, and measured blood levels rather than skin appearance or any health outcome. They answer whether absorption occurs, not whether it matters.

Photostability: the other chemical-filter question

There is a second, more formulation-focused issue. Avobenzone is a widely used UVA filter, but it is photounstable, meaning it degrades under UV. Formulators commonly add octocrylene to steady it, though a 2024 study notes octocrylene has recently been flagged for potential phototoxicity, and tested synthetic mycosporine-like amino acid analogues as alternatives. In their lab formulations, some analogues raised the UV dose needed to bleach half the avobenzone by up to two times. That is an early-stage finding on candidate stabilizers, not a product you can buy, but it shows why the full formula matters more than the single filter listed first.

How to choose, practically

1. Weigh the trade honestly. Chemical formulas are easier to wear and therefore easier to apply in the amount the SPF number assumes. A sunscreen left on the shelf offers no protection.
2. Consider a mineral or hybrid if absorption bothers you. The trials say nothing against sunscreen use, but if you prefer a lower-absorption option, a zinc oxide product is the usual alternative.
3. Check the filters, not only the SPF. Look for broad-spectrum labeling and note which filters are listed.
4. Apply generously and reapply. The trials used heavy application on purpose; real-world protection suffers more from too little product than from any filter choice.
5. Patch test if you react easily. Rash was the leading adverse event in both trials, and a small test on the inner arm costs little.
6. Talk to your doctor about products during pregnancy if you want personalized guidance.

The bottom line

The FDA trials established that common chemical filters are absorbed into the blood and that they pass the 0.5 ng/mL line that triggers more testing. They did not show harm, and their authors explicitly did not tell people to stop using sunscreen. For most people the practical decision is about wearability and consistent use. Choose the formula you will apply generously every day, and revisit your choice as new studies and regulatory decisions come out.